Matinas BioPharma Completes Enrollment in First Human Trial of MAT9001
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall St set for higher open as Anthropic's IPO filing sharpens AI focus
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
| (NYSE: MTNB) | Delayed: 1.58 -0.12 (7.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.70 | 52 Week High | $2.01 | |||
| Open | $1.59 | 52 Week Low | $0.41 | |||
| Day High | $1.64 | P/E | N/A | |||
| Day Low | $1.58 | EPS | $0.00 | |||
| Volume | 16,594 | |||||
